Susquehanna International Group
CLB icon

Susquehanna International Group’s Core Laboratories CLB Stock Holding History

Susquehanna International Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,200
Closed -$174K – 12138
2024
Q1 		$174K Buy
+10,200
New +$160K ﹤0.01% 10753
2022
Q4 		– Sell
-61,600
Closed -$830K – 12530
2022
Q3 		$830K Buy
61,600
+49,000
+389% +$826K ﹤0.01% 7115
2022
Q2 		$250K Sell
12,600
-8,400
-40% -$223K ﹤0.01% 10052
2022
Q1 		$664K Sell
21,000
-3,000
-13% -$84.1K ﹤0.01% 8220
2021
Q4 		$535K Sell
24,000
-2,500
-9% -$65.2K ﹤0.01% 9008
2021
Q3 		$735K Buy
26,500
+18,000
+212% +$548K ﹤0.01% 8369
2021
Q2 		$331K Sell
8,500
-6,400
-43% -$229K ﹤0.01% 10552
2021
Q1 		$429K Sell
14,900
-16,700
-53% -$571K ﹤0.01% 9824
2020
Q4 		$838K Sell
31,600
-20,400
-39% -$417K ﹤0.01% 7119
2020
Q3 		$794K Buy
52,000
+21,300
+69% +$447K ﹤0.01% 6684
2020
Q2 		$624K Buy
30,700
+14,900
+94% +$267K ﹤0.01% 6894
2020
Q1 		$163K Sell
15,800
-29,300
-65% -$819K ﹤0.01% 8909
2019
Q4 		$1.7M Buy
45,100
+19,100
+73% +$858K ﹤0.01% 4588
2019
Q3 		$1.21M Buy
26,000
+14,100
+118% +$656K ﹤0.01% 5281
2019
Q2 		$622K Sell
11,900
-30,500
-72% -$1.79M ﹤0.01% 6800
2019
Q1 		$2.92M Sell
42,400
-6,300
-13% -$422K ﹤0.01% 3168
2018
Q4 		$2.9M Buy
48,700
+17,000
+54% +$1.47M ﹤0.01% 2993
2018
Q3 		$3.67M Buy
31,700
+15,300
+93% +$1.73M ﹤0.01% 3085
2018
Q2 		$2.07M Sell
16,400
-5,300
-24% -$645K ﹤0.01% 3965
2018
Q1 		$2.35M Sell
21,700
-21,800
-50% -$2.41M ﹤0.01% 3621
2017
Q4 		$4.76M Sell
43,500
-34,100
-44% -$3.4M ﹤0.01% 2585
2017
Q3 		$7.66M Sell
77,600
-47,400
-38% -$4.59M ﹤0.01% 2037
2017
Q2 		$12.7M Buy
125,000
+59,500
+91% +$6.41M 0.01% 1516
2017
Q1 		$7.57M Buy
65,500
+9,800
+18% +$1.14M ﹤0.01% 1910
2016
Q4 		$6.69M Sell
55,700
-166,300
-75% -$18.4M ﹤0.01% 2014
2016
Q3 		$24.9M Buy
222,000
+97,200
+78% +$11.2M 0.01% 872
2016
Q2 		$15.5M Sell
124,800
-21,700
-15% -$2.62M 0.01% 1137
2016
Q1 		$16.5M Buy
146,500
+33,900
+30% +$3.52M 0.01% 1130
2015
Q4 		$12.2M Sell
112,600
-73,200
-39% -$8.38M 0.01% 1568
2015
Q3 		$18.5M Sell
185,800
-20,200
-10% -$2.2M 0.01% 1274
2015
Q2 		$23.5M Sell
206,000
-146,500
-42% -$17.8M 0.01% 1165
2015
Q1 		$36.8M Buy
352,500
+282,700
+405% +$30.1M 0.02% 801
2014
Q4 		$8.4M Sell
69,800
-89,600
-56% -$11.8M ﹤0.01% 2225
2014
Q3 		$23.3M Sell
159,400
-39,600
-20% -$6.11M 0.01% 1272
2014
Q2 		$33.2M Buy
199,000
+120,500
+154% +$21.4M 0.01% 963
2014
Q1 		$15.6M Buy
78,500
+15,700
+25% +$2.96M 0.01% 1519
2013
Q4 		$12M Buy
62,800
+46,000
+274% +$8.56M 0.01% 1843
2013
Q3 		$2.84M Sell
16,800
-4,100
-20% -$636K ﹤0.01% 3568
2013
Q2 		$3.17M Buy
+20,900
New +$2.96M ﹤0.01% 3205

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's CLB Position: Q1 2026 in Review

Susquehanna International Group increased its Core Laboratories (CLB) stake by 56% in Q1 2026, buying an estimated $209K and bringing the position to 32,350 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #9447.

Susquehanna International Group first reported a position in CLB in Q2 2013 and has held it in 46 quarters since. The position peaked at $16.9M in Q3 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Susquehanna International Group held 32,350 shares of Core Laboratories worth $543K as of Q1 2026.
  • Susquehanna International Group bought 11,657 Core Laboratories shares in Q1 2026, an estimated $209K.
  • Core Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9447 holding.
  • Susquehanna International Group first reported a position in Core Laboratories in Q2 2013 and has held it in 46 quarters since.
  • Susquehanna International Group's Core Laboratories position peaked at $16.9M in Q3 2014.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.